ArticleFrontiers in medicine2022

Corticosteroid Treatment Prevents Lipopolysaccharide-Induced Increase of ACE2 and Reduces Fibrin Degradation Products in Bronchoalveolar Lavage Fluid.

Roman Reindl-Schwaighofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.